In a long-overdue appearance, Saurabh Jha, MD, radiologist in Philadelphia, makes his triumphant return to the show to pick apart the single-payer model idea as well as FDA regulatory processes, this time with a worthy adversary: Adam Gaffney, MD, MPH, pulmonary specialist and health policy researcher at Cambridge Health Alliance/Harvard Medical School. The conversation begins with discussion of a proposed federal single-payer system in America, why it could not be modeled after a successful system like that in England, why significant health disparities exist geographically within a single-payer system and whether such a system can provide the tools to address these disparities, and so much more. Then, the conversation swings to whether a health care system should be designed to afford high-priced novel therapies because of failure to regulate these prices, on what basis the FDA should approve drugs, and other points of discussion. Things get testy in this spirited back-and-forth banter and you won’t want to miss it.
Observations and Commentary on Medicine and Current Events
